MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$173,912K
Net Income
-$18,810K
Net Profit Margin
-10.82%
EPS
-$0.43
Unit: Thousand (K) dollars
Revenue Breakdown
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
total revenues
173,912
162,054
151,668
118,697
Total operating expenses
193,820
168,176
159,644
133,226
Loss from operations before other income (expense)
-19,908
-6,122
-7,976
-14,529
Interest income
3,698
3,722
3,950
4,114
Interest expense
2,156
2,128
2,214
2,268
Loss on debt extinguishment
-
-
0
0
Gain on exchange of long-term investments
2,812
-
-
-
Other income (expense), net
-281
-87
-74
98
Total other income (expense), net
4,073
1,507
1,662
1,944
Loss before income taxes
-
-
-7,858*
-
Provision for income taxes
2,716
2,352
515*
-
Net loss
-18,551
-6,967
-8,373
-12,585
Unrealized gain (loss) on marketable securities and cash equivalents
-259
-679
92
250
Comprehensive loss
-18,810
-7,646
-8,281
-12,335
Basic EPS
-0.43
-0.16
-0.193
-0.3
Diluted EPS
-0.43
-0.16
-0.193
-0.3
Basic Average Shares
43,393,643
42,956,973
42,822,528
42,607,717
Diluted Average Shares
43,393,643
42,956,973
42,822,528
42,607,717
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
TARS Income Statement Sankey Diagram
Sankey diagram visualizing TARS income statement for the period
Comprehensive loss
-$18,810K
(7.73%↑ Y/Y)
Interest income
$3,698K
(-12.56%↓ Y/Y)
Gain on exchange of
long-term investments
$2,812K
Net loss
-$18,551K
(8.80%↑ Y/Y)
Unrealized gain (loss) on
marketable securities and...
-$259K
(-463.04%↓ Y/Y)
Total other income
(expense), net
$4,073K
(120.88%↑ Y/Y)
Product
$173,912K
(69.41%↑ Y/Y)
Interest expense
$2,156K
(-3.75%↓ Y/Y)
Other income
(expense), net
-$281K
(-93.79%↓ Y/Y)
Loss from operations
before other income...
-$19,908K
(10.26%↑ Y/Y)
total revenues
$173,912K
(69.41%↑ Y/Y)
Provision for income taxes
$2,716K
Total operating
expenses
$193,820K
(55.25%↑ Y/Y)
Buy us a coffee
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)